| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.04 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |